Company news
Prf Technologies Ltd. (NASDAQ:PRFX) news
Every Prf Technologies Ltd. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
PRF Technologies to Establish GridFeed™ as a Standalone Subsidiary to Pursue Strategic Alliances for Its AI-Driven Renewable Energy Tradi...
September 9, 2026
PRF Technologies : Provides First Half 2026 Business Update Highlighting Significant Progress Across Healthcare and AI Energy Business
September 3, 2026
PRF Technologies Issues Letter to Shareholders Highlighting Strengthened Financial Position and Building Momentum Across Its Biotechnolog...
July 27, 2026
PRF Technologies to Showcase GridFeed™ at Energy Trading Week Europe 2026
July 21, 2026
PRF Technologies Expands DeepSolar Predict Platform with Battery-to-Revenue Intelligence, Extending AI-Driven Revenue Optimization Across...
July 16, 2026
PRF Technologies Expands DeepSolar Predict™ Platform with Battery-to-Revenue Intelligence, Extending AI-Driven Revenue Optimization Acros...
July 15, 2026
PRF Technologies’ DeepSolar Successfully Validates Predict™ AI Platform for Renewable Energy Revenue Optimization Using Real-World Europe...
July 8, 2026
PRF Technologies Reports Expanded Preclinical Results for PRF-110 in Head-to-Head Comparison with Approved Benchmark
June 25, 2026
PRF Technologies Advances DeepSolar Predict™ Toward Commercial Launch as AI Platform Targets Revenue Optimization Across Renewable Energy...
May 28, 2026
PRF Technologies Announces PRF-110 Demonstrated Sustained 72-Hour Analgesic Activity Comparable to Approved, Commercially Available Bench...
May 26, 2026
PRF Technologies Announces FDA Clearance of IND Application for OcuRing™-K Phase II Clinical Trial
April 28, 2026
PRF Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across Healthcare and AI-Driven Solar Platforms
March 27, 2026
PRF Technologies Ltd. Announces Commercial Collaboration Agreement with Blade Ranger to Accelerate Large-Scale DeepSolar Commercial Engag...
March 17, 2026
PRF Technologies’ DeepSolar Announces its First Commercial Due Diligence Engagement with EDF Power Solutions Israel, a Global Leader in R...
February 18, 2026
PRF Technologies Wins Another European Utility-Scale Solar Deployment, Expanding DeepSolar’s Installed Commercial Base
February 11, 2026
PRF Technologies Files Its First Patent Application for Solar Plant Micro-Climate Forecast Modeling Designed to Improve Energy Production...
January 20, 2026
PainReform Ltd. Changes Name to PRF Technologies Ltd. Reflecting Expansion into Diversified Healthcare and AI-Driven Energy Platforms
January 15, 2026
PainReform’s LayerBio’s Drop-Less OcuRing™-K Delivery Platform Demonstrates Favorable Safety Profile in Preclinical and Phase I Clinical ...
January 12, 2026
PainReform’s DeepSolar Launches Smart TDD, a Next-Generation Solar Due Diligence Service Targeting the $60B+ Global Solar Asset M&A Market
January 5, 2026
BladeRanger to Showcase Advanced Green Energy Technologies at Abu Dhabi Sustainability Week
December 30, 2025
PainReform Confirms the Ability of Its LayerBio Drop-Less Sustained-Release Ocular Platform to Accommodate Multiple Drug Entities
December 10, 2025
PainReform Commences Development for OcuRing™-K Phase II Trial, LayerBio’s Drop-Less Sustained-Release Ocular Therapy
December 2, 2025
PainReform’s DeepSolar Advances Development of its AI-Driven Automated Reporting Engine for Solar-Asset Analysis
November 12, 2025
PainReform’s DeepSolar, Developing “DeepSolar Predict” within the NVIDIA Connect Program, Featured in The Market Link’s “Watchlist Interv...
November 5, 2025
PainReform Provides Business Update for the Six Months Ended June 30, 2025
October 1, 2025
PainReform/DeepSolar Accepted into NVIDIA Connect Program
August 19, 2025
PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-...
August 13, 2025
PainReform Ltd. enters into a Strategic Investment Agreement to Expand its Non-Opiate Pain Management Pipeline into Opthamology with Laye...
July 10, 2025
Blade Ranger: Consideration from PainReform Transaction Continues to Mature Following Growth in Software Sales
May 27, 2025
PainReform Launches Strategic AI Pilot with Econergy Using Its Proprietary DeepSolar™ Platform to Optimize One of Romania’s Largest Solar...
May 7, 2025
PainReform Expands into Home Energy Management Sector, Leveraging DeepSolar’s AI-Driven Platform to Address the Growing Solar Optimizatio...
April 10, 2025
PainReform Provides Year-End Business Update
April 7, 2025
PainReform Completes Strategic Acquisition of DeepSolar, Unlocking New Growth Opportunities in AI-Driven Solar Analytics
March 5, 2025
PainReform Executes Definitive Agreement to Acquire DeepSolar, Marking a Unique Expansion Opportunity
February 18, 2025
PainReform Provides Further Update on Phase 3 Clinical Trial of PRF-110
December 27, 2024
PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial
November 20, 2024
PainReform Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement
November 7, 2024
PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110
September 11, 2024
PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds
September 10, 2024
PainReform Announces Positive Safety Profile for PRF-110 in Phase 3 Bunionectomy Study
August 20, 2024
PainReform Provides Business Update for the Second Quarter of 2024
August 15, 2024
PainReform Announces Development and Successful Manufacturing of New Formulations Providing Anti-Inflammatory and Extended Analgesic Effects
August 12, 2024
PainReform Announces Favorable Safety Profile of PRF-110, Indicating Potential for Use in New Surgical Applications Requiring Higher Doses
August 7, 2024
PainReform Ltd. Announces Favorable Wound Healing Data in Human Clinical Trials for PRF-110
August 5, 2024
PainReform’s New Manufacturing Process Achieves Significant Benefits Including 18-Month Stability of PRF-110 at Room Temperature
August 1, 2024
PainReform Files Patent Covering Highly Scalable Manufacturing Process for PRF-110 Following Successful Completion and Testing
July 24, 2024
PainReform Completes Enrollment in the Second Part of its Phase 3 Bunionectomy Trial for PRF-110
June 26, 2024
PainReform Provides Business Update for the First Quarter of 2024
May 15, 2024
PainReform Advances Pain Relief Solution, PRF-110, in Phase 3 Trial to Combat Opioid Crisis
May 7, 2024
PainReform Announces Closing of $4 Million Public Offering
April 18, 2024